Heart Attack Diagnostics Market Analysis

  • Report ID: 4446
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT

Heart Attack Diagnostics Market Segmentation:

End-user Segment Analysis

The global heart attack diagnostics market is segmented and analyzed for demand and supply by end-user into hospitals & clinics, diagnostic center, and ambulatory & surgical centers. Out of which, the hospitals & clinics segment is projected to witness noteworthy growth over the forecast period. The growth of the segment can be accounted to the high number of surgical procedures performed in hospital settings, and the high number of hospitals present in the world. It was observed that more than 850,000 cardiac surgeries are performed each year in the United States. Moreover, the rising number of heart patient admissions in hospitals along with the increasing pharma sector is anticipated to augment segment growth over the forecast period.

Test Segment Analysis

Furthermore, the global heart attack diagnostics market is segmented and analyzed for demand and supply by test into electrocardiography, blood tests, computerized cardiac tomography, echocardiography, coronary angiography, and others. Out of which, the electrocardiography (ECG) segment is projected to witness noteworthy growth over the forecast period. The growth of the segment is boosted by the fact that it is the first and mandatory test that is performed to diagnose heart attack when the patients get admitted to the hospitals. Based on the data provided by the World Health Organization (WHO), it was stated that in 2019, around 17.9 million people across the globe lost their lives owing to cardiovascular diseases (CVDs), out of which, 85% were caused by a heart attack. Hence, such a higher prevalence of heart attacks is estimated to hike the number of echocardiography test performed in the hospitals over the forecast period. Furthermore, there has been advancement in the ECG devices for diagnosing heart attack, and it is expected to drive the growth of the segment in the heart attack diagnostics market.

Our in-depth analysis of the global heart attack diagnostics market includes the following segments:

               By Type

  • Non-Invasive
  • Minimally Invasive

              By Test

  • Electrocardiography
  • Blood Tests
  • Computerized Cardiac Tomography
  • Echocardiography
  • Coronary Angiography
  • Others

               By End User

  • Hospitals & Clinics
  • Diagnostic Center
  • Ambulatory & Surgical Centers

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of heart attack diagnostics is evaluated at USD 14.03 billion.

The global heart attack diagnostics market size was worth over USD 13.14 billion in 2025 and is poised to grow at a CAGR of around 7.5%, reaching USD 27.08 billion revenue by 2035.

The North America heart attack diagnostics market will dominate over 39.3% share by 2035, fueled by rising cardiac disease incidence, high healthcare spending, and advanced infrastructure.

Key players in the market include Abbott Laboratories, ACS Diagnostics, Company, Asahi Kasei Corporation, AstraZeneca PLC, Beckman Coulter, Inc., Hill-Rom Services, Inc, Koninklijke Philips N.V., General Electric Company, Toshiba Corporation, Schiller Americas, inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos